NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spirit Aviation Holdings, Inc. (“Spirit” or the “Company”) (NYSE: FLYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spirit and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Aug ...

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Broadwind, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers [1] - Broadwind reported a GAAP loss per share of $0.04 for Q2 2025, missing consensus estimates by $0.05, and suspended its full-year 2025 financial guidance due to the sale of its industrial fabrication operations [3] - Following the announcement of its financial results, Broadwind's stock price dropped by $0.36, or 14.46%, closing at $2.13 per share on August 12, 2025 [4] Company Financial Performance - Broadwind reported a GAAP loss per share of $0.04 for Q2 2025, which was below the consensus estimate by $0.05 [3] - The company suspended its previously issued full-year 2025 financial guidance due to a definitive agreement to sell its industrial fabrication operations in Manitowoc, Wisconsin [3] Stock Market Reaction - Broadwind's stock price fell by $0.36, representing a 14.46% decrease, closing at $2.13 per share on August 12, 2025, following the financial results announcement [4]

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. and certain officers for alleged violations of federal securities laws during the Class Period from August 8, 2024, to August 14, 2025, seeking damages for affected investors [1][2]. Company Overview - Nutex Health Inc. is a physician-led healthcare services company that operates through three divisions: a hospital division with 24 facilities across 11 states, a population health management division, and real estate [4]. - The company primarily operates as an out-of-network provider, generating over 90% of its net patient service revenue from third-party payors, including commercial insurance and workers' compensation [4]. Legislative Context - The No Surprises Act (NSA), effective January 1, 2022, was enacted to prevent surprise out-of-network billing, requiring private health plans to cover out-of-network claims at in-network cost-sharing rates [6]. - The NSA established an independent dispute resolution (IDR) process for determining out-of-network payment amounts when negotiations fail [7]. Financial Impact - Following the implementation of the NSA, Nutex's average payment from insurers for emergency services declined by approximately 30%, with a 37% reduction for physician services reported in March 2023 [8]. - In 2024, Nutex's total revenue increased by $232.3 million to $479.9 million, with the arbitration process contributing approximately $169.7 million to this revenue increase [9]. Internal Control Issues - Nutex has acknowledged material weaknesses in its internal controls over financial reporting, including ineffective design and implementation of controls related to financial processes [9]. - The company has stated it is in the process of remediating these weaknesses [9]. Allegations and Lawsuits - The lawsuit alleges that Nutex made materially false and misleading statements regarding its business operations and financial prospects, including claims about the sustainability of revenues from its engagement with HaloMD in the IDR process [9]. - Blue Orca Capital's report accused HaloMD of engaging in fraudulent schemes to inflate payments from insurance companies, which could impact Nutex's financial stability [10][11]. Stock Price Reaction - Following the publication of the Blue Orca Report, Nutex's stock price fell by $11.18 per share (10.05%) on July 22, 2025, and further declined by $18.22 per share (16.39%) after the company announced a delay in filing its Form 10-Q on August 15, 2025 [11][13]. Recent Developments - On August 21, 2025, Nutex filed a Current Report with the SEC indicating that certain financial statements would need to be restated due to improper treatment of non-cash obligations [14].

Group 1 - The core issue involves potential securities fraud claims against Petco Health and Wellness Company, linked to a class action lawsuit regarding misleading statements about its pandemic-related growth and the sustainability of its premium pet food business model [1][2] - Petco's stock price experienced significant declines, including a drop of over 20% on August 24, 2023, following a downward revision of its financial outlook, compounded by leadership changes and ongoing operational challenges [2][3] - The lawsuit highlights that Petco's shift to include "value" pet food brands and multiple executive departures indicated deeper operational weaknesses, leading to increased losses for investors [3] Group 2 - The class period for the lawsuit is defined as January 14, 2021, through June 5, 2025, allowing investors who acquired Petco stock during this timeframe to seek lead plaintiff status by August 29, 2025 [3] - Berger Montague, the firm investigating the claims, has a long history in securities class action litigation, representing investors for over five decades [5]

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Flywire Corporation for alleged misrepresentations regarding the company's revenue growth between February 28, 2024, and February 25, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Flywire securities during the specified period [1]. - The complaint alleges that the defendants made false statements about the strength and sustainability of Flywire's revenue growth [2]. Group 2: Legal Process - Investors wishing to serve as lead plaintiff must file necessary documents by September 23, 2025 [3]. - Participation as a lead plaintiff is not required to share in any potential recovery from the lawsuit [3]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions [4].

Core Viewpoint - A class action lawsuit has been filed against PubMatic, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company regarding its business operations and financial performance [1][4]. Group 1: Lawsuit Details - The lawsuit is based on allegations that PubMatic made false and misleading statements to the market, particularly about a significant buyer shifting clients to a competing platform, which negatively impacted the company's inventory and ad spend [4]. - The class period for the lawsuit is defined as from February 27, 2025, to August 11, 2025, during which investors are encouraged to contact the Schall Law Firm if they suffered losses [2]. Group 2: Investor Participation - Investors who purchased PubMatic securities during the class period are urged to reach out to the Schall Law Firm before October 20, 2025, to discuss their rights and potential participation in the lawsuit [2][3]. - The class has not yet been certified, meaning that until certification occurs, affected investors are not represented by an attorney [3]. Group 3: Company Impact - The lawsuit claims that the misleading statements led to significant damages for investors once the truth about PubMatic's business situation was revealed [4].

Core Insights - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, with a focus on its sales growth and inventory practices [1][2] - The company's primary brands, Premier Protein and Dymatize, have reported strong demand, but this may be misleading due to temporary inventory loading at retailers [2] - Recent stock price declines indicate market concerns over the sustainability of BellRing's growth and actual consumer demand [3][4] Group 1: Company Performance - BellRing Brands operates in the convenient nutrition category, primarily offering ready-to-drink protein shakes and powders [2] - The company claimed that Premier Protein achieved an all-time high in household penetration, with strong growth across all channels [2] - However, the sales growth may not be sustainable, as it could be attributed to temporary trade inventory loading rather than genuine consumer demand [2] Group 2: Stock Market Reaction - On May 5, 2025, BellRing disclosed that key retailers reduced their inventory levels, which would negatively impact growth in Q3 2025, leading to a stock price drop of over 18% [3] - Following disappointing quarterly consumption figures for Premier Protein RTD Shakes on August 4, 2025, the stock fell nearly 33% the next day, indicating significant market reaction to the company's performance [4]

Core Viewpoint - A class action securities lawsuit has been filed against Fiserv, Inc. alleging securities fraud that negatively impacted investors between July 24, 2024, and July 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Fiserv made false statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older platform [2]. - It is alleged that the revenue growth of Clover was artificially inflated by the forced conversions, masking a slowdown in acquiring new merchants [2]. - Following the conversions, many former Payeezy merchants reportedly switched to competitors due to Clover's high pricing and poor customer service, leading to a significant slowdown in Clover's growth [2]. - The lawsuit asserts that Fiserv's positive statements about Clover's growth strategies and business prospects were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified period have until September 22, 2025, to request to be appointed as lead plaintiff in the case [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased iRobot Corporation securities between January 29, 2024, and March 11, 2025, of the September 5, 2025, deadline to become a lead plaintiff in a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought iRobot securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 5, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that iRobot made false and misleading statements regarding its Restructuring Plan and its ability to operate profitably as a standalone company [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise in this area [3].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices by The Trade Desk, Inc. and its officers or directors following disappointing financial results and subsequent stock price decline [1][2]. Financial Performance - The Trade Desk reported disappointing second quarter 2025 financial results after the market closed on August 7, 2025, leading to multiple downgrades from analysts, including a double downgrade by Bank of America [2]. - The company missed guidance for the first time as a public entity, raising concerns about competitive pressures and its ability to sustain over 20% long-term growth [2]. Stock Market Reaction - Following the negative news, The Trade Desk's stock price fell by $34.10 per share, or 38.6%, closing at $54.23 per share on August 8, 2025 [3]. Management Changes - The Trade Desk announced the departure of its longtime Chief Financial Officer, which may further impact investor confidence and company performance [2].